Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | OBP-301 |
Trade Name | |
Synonyms | OBP301|OBP 301|Telomelysin|Telomelycin|Suratadenoturev |
Drug Descriptions |
OBP-301 (telomelysin) is an oncolytic adenovirus that may increase tumor cell lysis and radiosensitivity (J Clin Onc 2019 37:4_suppl, 130). |
DrugClasses | |
CAS Registry Number | 1160991-31-0 |
NCIT ID | C119617 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Carboplatin + OBP-301 + Paclitaxel | Carboplatin OBP-301 Paclitaxel | 0 | 1 |
OBP-301 | OBP-301 | 0 | 0 |
OBP-301 + Pembrolizumab | OBP-301 Pembrolizumab | 0 | 3 |
OBP-301 + Radiotherapy | OBP-301 Radiotherapy | 0 | 0 |